skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: 1,4-Dihydropyridinebutyrolactone-derived ring-opened ester and amide analogs targeting BET bromodoma

Journal Article · · Arch. Pharm.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Institutes of Health (NIH)
OSTI ID:
1901119
Journal Information:
Arch. Pharm., Vol. 355, Issue (11)
Country of Publication:
United States
Language:
ENGLISH

References (52)

Bromodomain: an acetyl-lysine binding domain journal January 2002
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family journal March 2012
The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation journal October 2007
Structural Mechanism of Transcriptional Regulator NSD3 Recognition by the ET Domain of BRD4 journal July 2016
The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators journal May 2018
Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains journal February 2019
The Bromodomain Protein Brd4 Is a Positive Regulatory Component of P-TEFb and Stimulates RNA Polymerase II-Dependent Transcription journal August 2005
Brd4 and JMJD6-Associated Anti-Pause Enhancers in Regulation of Transcriptional Pause Release journal December 2013
The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3 journal May 2011
The Conserved 12-Amino Acid Stretch in the Inter-Bromodomain Region of BET Family Proteins Functions as a Nuclear Localization Signal journal January 2012
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc journal September 2011
Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2 journal May 2011
c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells journal September 2012
Overexpression of c-myc is associated with adverse clinical features and worse overall survival in multiple myeloma journal May 2016
Small-Molecule Inhibition of BRDT for Male Contraception journal August 2012
Expression of BET genes in testis of men with different spermatogenic impairments journal January 2012
The first bromodomain of the testis-specific double bromodomain protein Brdt is required for chromocenter organization that is modulated by genetic background journal December 2011
Discovery and characterization of bromodomain 2–specific inhibitors of BRDT journal February 2021
Selective inhibition of BET bromodomains journal September 2010
Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains journal September 2013
Discovery of N -(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1 H -pyrrolo[2,3- c ]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor journal October 2017
Clinical trials for BET inhibitors run ahead of the science journal March 2016
4-Methyl-1,2,3-Triazoles as N -Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Improved Selectivity journal July 2021
Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit journal July 2021
Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors journal July 2021
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors journal July 2021
Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site journal January 2022
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation journal March 2020
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer journal January 2020
Design and characterization of bivalent BET inhibitors journal October 2016
Spatially constrained tandem bromodomain inhibition bolsters sustained repression of BRD4 transcriptional activity for TNBC cell growth journal July 2018
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation journal July 2001
Plasticity in binding confers selectivity in ligand-induced protein degradation journal June 2018
First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity journal March 2019
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors journal October 2018
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors journal November 2019
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours journal September 2020
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition journal September 2015
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer journal January 2016
AMPK–ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells journal May 2017
BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen journal June 2017
BRDT Inhibitors for Male Contraceptive Drug Discovery: Current Status book January 2018
Molecular complexes at a glance: automated generation of two-dimensional complex diagrams journal April 2006
Importance of Purity Evaluation and the Potential of Quantitative 1 H NMR as a Purity Assay: Miniperspective journal October 2014
Correction to Importance of Purity Evaluation and the Potential of Quantitative 1H NMR as a Purity Assay journal November 2015
A Bead-Based Proximity Assay for BRD4 Ligand Discovery: Proximity Assay for BRD4 Ligand Discovery journal November 2015
Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors journal October 2021
XDS journal January 2010
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Features and development of Coot journal March 2010
MolProbity : all-atom structure validation for macromolecular crystallography journal December 2009
phenix.model_vs_data : a high-level tool for the calculation of crystallographic model and data statistics journal May 2010